In other developments, it has been discovered that the risk of thromboembolic diseases is high in men who have prostate cancer. This related to one of the treatment approaches to prostate cancer known as Endocrine treatment whose basis is the interruption of the regulation of prostate tumor by testosterone (Hemelrijck & Garmo, 2010). Though treatment with endocrine treatment method is known to have many metabolic side effects, the increased risk of cardiovascular disease has been discovered recently.
It is believed that the interruption of testosterone levels in the body lowers the protective function of testosterone on heart thus predisposing to heart diseases (Hemelrijck & Garmo, 2010). In a study done to find out the relationship between heart diseases and various approaches to prostate cancer treatment showed that though the rates of heart diseases were high in prostate cancer patients, the rates were particularly high for the patients treated with endocrine treatment method (Hemelrijck & Garmo, 2010).
The most common heart diseases were found to be pulmonary embolism and deep-venous thrombosis. It is important to note that at present treatment with Endocrine treatment method is the only treatment that is effective against metastatic prostatic cancer (Hemelrijck & Garmo, 2010). Following these findings the researchers have recommended consideration of the risk of heart diseases when prescribing endocrine treatment as the method of treatment (Hemelrijck & Garmo, 2010).
It is clear that developments on prostate cancer are many and they range from positive to negative developments. It is through these developments that this disease is being understood and with proper understanding will come better treatment methods-treatment methods whose side effects are minimized. References Butler, L. M. , Wong, A. S. , & Koh, W. P. (2010). Calcium intake increases risk of prostate cancer among Singapore Chinese. Cancer Research, 70, 4941-4948. Hemelrijck, M. V. & Garmo, H. (2010).
Absolute and relative risk of cardiovascular disease in men with prostate cancer: Results from the population based PCBaSe Sweden. Journal of Clinical oncology, 28(21), 3448-3456. Ma, R. W. & Chapman, K. (2009). A systematic review of the effect of diet in prostate cancer prevention and treatment. Journal of Human Nutrition and Dietetics, 22(3), 187-199. Murad, A. S. & Down, L. (2010).
Associations of aspirin, nonsteroidal anti-inflammatory drug and paracetamol use with PSA-detected prostate cancer: Findings from a large, population-based, case-control study (the ProtecT study). International Journal of Cancer, 156(3), 37-41. Pestell, R. G. & Nevalainen, M. T. (2008). Prostate cancer: Signaling networks, genetics, and new treatment strategies. Totowa, NJ: Humana Press. Yeager, M. (2008). Comprehensive resequence analysis of a 136 kb region of human chromosome 8q24 associated with prostate and colon cancers. Human Genetics, 124(2), 161-170.